Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vecihi Batuman

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Blood|October 6, 2005
Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injuryAkira Arimura, Min Li, Vecihi Batuman
Kidney International Reports|May 20, 2021
The Proximal Tubule Toxicity of Immunoglobulin Light ChainsChristophe Sirac, Vecihi Batuman, Paul W Sanders
Kidney International Supplements|July 15, 2014
Hypertension and chronic kidney disease in TurkeySule Sengul, Yunus Erdem, Vecihi Batuman, et al.
Biomarkers in Medicine|December 8, 2010
Emergence of biomarkers in nephropharmacologyEnver Khan, Vecihi Batuman, Juan J L Lertora
Plos One|July 30, 2013
Receptor-associated protein blocks internalization and cytotoxicity of myeloma light chain in cultured human proximal tubular cellsSule Sengul, Sehsuvar Erturk, Altaf M Khan, et al.
American Journal of Physiology. Renal Physiology|May 2, 2008
Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cellsMin Li, Saravanan Balamuthusamy, Eric E Simon, et al.
Environmental Research|March 15, 2008
Estimated burden of blood lead levels 5 microg/dl in 1999-2002 and declines from 1988 to 1994Shahed Iqbal, Paul Muntner, Vecihi Batuman, et al.
The American Journal of the Medical Sciences|April 18, 2018
Fatal Hypermagnesemia Due to Laxative UseSyed Rizwan Bokhari, Ravi Siriki, Federico J Teran, et al.
Cancer Research|September 5, 2006
Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cellsMin Li, Shirley Cortez, Tomoya Nakamachi, et al.
BMC Nephrology|April 30, 2009
Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal studyWilfried Karmaus, Plamen Dimitrov, Valeri Simeonov, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Blood|October 6, 2005
Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injuryAkira Arimura, Min Li, Vecihi Batuman
Kidney International Reports|May 20, 2021
The Proximal Tubule Toxicity of Immunoglobulin Light ChainsChristophe Sirac, Vecihi Batuman, Paul W Sanders
Kidney International Supplements|July 15, 2014
Hypertension and chronic kidney disease in TurkeySule Sengul, Yunus Erdem, Vecihi Batuman, et al.
Biomarkers in Medicine|December 8, 2010
Emergence of biomarkers in nephropharmacologyEnver Khan, Vecihi Batuman, Juan J L Lertora
Plos One|July 30, 2013
Receptor-associated protein blocks internalization and cytotoxicity of myeloma light chain in cultured human proximal tubular cellsSule Sengul, Sehsuvar Erturk, Altaf M Khan, et al.
American Journal of Physiology. Renal Physiology|May 2, 2008
Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cellsMin Li, Saravanan Balamuthusamy, Eric E Simon, et al.
Environmental Research|March 15, 2008
Estimated burden of blood lead levels 5 microg/dl in 1999-2002 and declines from 1988 to 1994Shahed Iqbal, Paul Muntner, Vecihi Batuman, et al.
The American Journal of the Medical Sciences|April 18, 2018
Fatal Hypermagnesemia Due to Laxative UseSyed Rizwan Bokhari, Ravi Siriki, Federico J Teran, et al.
Cancer Research|September 5, 2006
Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cellsMin Li, Shirley Cortez, Tomoya Nakamachi, et al.
BMC Nephrology|April 30, 2009
Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal studyWilfried Karmaus, Plamen Dimitrov, Valeri Simeonov, et al.
Pageof 8